TaiMed Biologics Inc. (TPEX:4147)
Taiwan
· Delayed Price · Currency is TWD 50.70
-2.80 (-5.23%)
Mar 9, 2026, 1:30 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 13.85 billion as of March 9, 2026. Its market cap has decreased by -43.58% in one year.
Market Cap
13.85B
Enterprise Value
12.59B
Revenue
607.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.70
Market Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 13.85B, an increase of 436.78%. That is a compound annual growth rate of 11.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AP Biosciences | 14.46B |
| TCM Biotech International | 14.02B |
| Ever Supreme Bio Technology | 12.66B |
| Medigen Vaccine Biologics | 12.10B |
| Tanvex BioPharma | 11.86B |
| EirGenix | 18.10B |
| Sunmax Biotechnology | 21.21B |
| Gongwin Biopharm Holdings | 9.81B |